Which has better valuation & earnings, HHH or CG?

Carlyle Group has higher revenue and earnings than Howard Hughes. Carlyle Group is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Howard Hughes $1.51B 2.93 $131.88M $2.04 36.47 Carlyle Group $4.78B 3.21 $808.70M $1.46 29.17

Which has preferable valuation & earnings, HHH or TPG?

TPG has higher revenue and earnings than Howard Hughes. Howard Hughes is trading at a lower price-to-earnings ratio than TPG, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Howard Hughes $1.51B 2.93 $131.88M $2.04 36.47 TPG $4.67B 3.40 $184.59M $0.22 187.68

Is HHH or TPG more profitable?

Howard Hughes has a net margin of 8.04% compared to TPG's net margin of 3.81%. TPG's return on equity of 28.13% beat Howard Hughes' return on equity. Company Net Margins Return on Equity Return on Assets Howard Hughes 8.04% 5.41% 1.61% TPG 3.81% 28.13% 8.25%

Howard Hughes (HHH) Competitors

$74.40 +1.87 (+2.57%)

As of 02:29 PM Eastern

Compare

HHH vs. TSHA, CG, TPG, REG, and DOC

Should you buy Howard Hughes stock or one of its competitors? MarketBeat compares Howard Hughes with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Howard Hughes include Taysha Gene Therapies (TSHA), Carlyle Group (CG), TPG (TPG), Regency Centers (REG), and Healthpeak Properties (DOC).

How does Howard Hughes compare to Taysha Gene Therapies?

Howard Hughes (NYSE:HHH) and Taysha Gene Therapies (NASDAQ:TSHA) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Howard Hughes	$1.51B	2.93	$131.88M	$2.04	36.47
Taysha Gene Therapies	$9.77M	189.24	-$109M	-$0.38	N/A

Howard Hughes has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Taysha Gene Therapies has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

93.8% of Howard Hughes shares are held by institutional investors. Comparatively, 77.7% of Taysha Gene Therapies shares are held by institutional investors. 48.0% of Howard Hughes shares are held by insiders. Comparatively, 3.8% of Taysha Gene Therapies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Taysha Gene Therapies had 9 more articles in the media than Howard Hughes. MarketBeat recorded 9 mentions for Taysha Gene Therapies and 0 mentions for Howard Hughes. Taysha Gene Therapies' average media sentiment score of 0.64 beat Howard Hughes' score of 0.00 indicating that Taysha Gene Therapies is being referred to more favorably in the news media.

Company	Overall Sentiment
Howard Hughes	Neutral
Taysha Gene Therapies	Positive

Howard Hughes has a net margin of 8.04% compared to Taysha Gene Therapies' net margin of 0.00%. Howard Hughes' return on equity of 5.41% beat Taysha Gene Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Howard Hughes	8.04%	5.41%	1.61%
Taysha Gene Therapies	N/A	-56.07%	-40.16%

Howard Hughes presently has a consensus price target of $85.00, indicating a potential upside of 14.25%. Taysha Gene Therapies has a consensus price target of $12.62, indicating a potential upside of 96.07%. Given Taysha Gene Therapies' stronger consensus rating and higher probable upside, analysts plainly believe Taysha Gene Therapies is more favorable than Howard Hughes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Howard Hughes	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Taysha Gene Therapies	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Howard Hughes beats Taysha Gene Therapies on 9 of the 17 factors compared between the two stocks.

How does Howard Hughes compare to Carlyle Group?

Howard Hughes (NYSE:HHH) and Carlyle Group (NASDAQ:CG) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

93.8% of Howard Hughes shares are owned by institutional investors. Comparatively, 55.9% of Carlyle Group shares are owned by institutional investors. 48.0% of Howard Hughes shares are owned by company insiders. Comparatively, 25.4% of Carlyle Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Carlyle Group had 10 more articles in the media than Howard Hughes. MarketBeat recorded 10 mentions for Carlyle Group and 0 mentions for Howard Hughes. Carlyle Group's average media sentiment score of 0.58 beat Howard Hughes' score of 0.00 indicating that Carlyle Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Howard Hughes	Neutral
Carlyle Group	Positive

Howard Hughes presently has a consensus price target of $85.00, indicating a potential upside of 14.25%. Carlyle Group has a consensus price target of $62.00, indicating a potential upside of 45.57%. Given Carlyle Group's stronger consensus rating and higher possible upside, analysts plainly believe Carlyle Group is more favorable than Howard Hughes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Howard Hughes	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Carlyle Group	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.29

Howard Hughes has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market. Comparatively, Carlyle Group has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market.

Carlyle Group has a net margin of 13.46% compared to Howard Hughes' net margin of 8.04%. Carlyle Group's return on equity of 20.95% beat Howard Hughes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Howard Hughes	8.04%	5.41%	1.61%
Carlyle Group	13.46%	20.95%	5.28%

Carlyle Group has higher revenue and earnings than Howard Hughes. Carlyle Group is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Howard Hughes	$1.51B	2.93	$131.88M	$2.04	36.47
Carlyle Group	$4.78B	3.21	$808.70M	$1.46	29.17

Summary

Carlyle Group beats Howard Hughes on 12 of the 16 factors compared between the two stocks.

How does Howard Hughes compare to TPG?

Howard Hughes (NYSE:HHH) and TPG (NASDAQ:TPG) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Howard Hughes has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market. Comparatively, TPG has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

Howard Hughes presently has a consensus price target of $85.00, indicating a potential upside of 14.25%. TPG has a consensus price target of $61.75, indicating a potential upside of 49.55%. Given TPG's stronger consensus rating and higher probable upside, analysts clearly believe TPG is more favorable than Howard Hughes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Howard Hughes	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
TPG	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65

TPG has higher revenue and earnings than Howard Hughes. Howard Hughes is trading at a lower price-to-earnings ratio than TPG, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Howard Hughes	$1.51B	2.93	$131.88M	$2.04	36.47
TPG	$4.67B	3.40	$184.59M	$0.22	187.68

In the previous week, TPG had 15 more articles in the media than Howard Hughes. MarketBeat recorded 15 mentions for TPG and 0 mentions for Howard Hughes. TPG's average media sentiment score of 0.04 beat Howard Hughes' score of 0.00 indicating that TPG is being referred to more favorably in the news media.

Company	Overall Sentiment
Howard Hughes	Neutral
TPG	Neutral

93.8% of Howard Hughes shares are held by institutional investors. Comparatively, 94.0% of TPG shares are held by institutional investors. 48.0% of Howard Hughes shares are held by insiders. Comparatively, 70.0% of TPG shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Howard Hughes has a net margin of 8.04% compared to TPG's net margin of 3.81%. TPG's return on equity of 28.13% beat Howard Hughes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Howard Hughes	8.04%	5.41%	1.61%
TPG	3.81%	28.13%	8.25%

Summary

TPG beats Howard Hughes on 14 of the 16 factors compared between the two stocks.

How does Howard Hughes compare to Regency Centers?

Regency Centers (NASDAQ:REG) and Howard Hughes (NYSE:HHH) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

96.1% of Regency Centers shares are owned by institutional investors. Comparatively, 93.8% of Howard Hughes shares are owned by institutional investors. 1.0% of Regency Centers shares are owned by insiders. Comparatively, 48.0% of Howard Hughes shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Regency Centers had 10 more articles in the media than Howard Hughes. MarketBeat recorded 10 mentions for Regency Centers and 0 mentions for Howard Hughes. Regency Centers' average media sentiment score of 1.12 beat Howard Hughes' score of 0.00 indicating that Regency Centers is being referred to more favorably in the media.

Company	Overall Sentiment
Regency Centers	Positive
Howard Hughes	Neutral

Regency Centers has higher revenue and earnings than Howard Hughes. Regency Centers is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Regency Centers	$1.55B	9.48	$527.46M	$2.90	27.72
Howard Hughes	$1.51B	2.93	$131.88M	$2.04	36.47

Regency Centers presently has a consensus price target of $82.63, indicating a potential upside of 2.77%. Howard Hughes has a consensus price target of $85.00, indicating a potential upside of 14.25%. Given Howard Hughes' higher probable upside, analysts plainly believe Howard Hughes is more favorable than Regency Centers.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Regency Centers	0 Sell rating(s)	11 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.55
Howard Hughes	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Regency Centers has a net margin of 34.47% compared to Howard Hughes' net margin of 8.04%. Regency Centers' return on equity of 7.99% beat Howard Hughes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Regency Centers	34.47%	7.99%	4.22%
Howard Hughes	8.04%	5.41%	1.61%

Regency Centers has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Howard Hughes has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market.

Summary

Regency Centers beats Howard Hughes on 13 of the 17 factors compared between the two stocks.

How does Howard Hughes compare to Healthpeak Properties?

Healthpeak Properties (NYSE:DOC) and Howard Hughes (NYSE:HHH) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Healthpeak Properties has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, Howard Hughes has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

Howard Hughes has a net margin of 8.04% compared to Healthpeak Properties' net margin of 7.73%. Howard Hughes' return on equity of 5.41% beat Healthpeak Properties' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Healthpeak Properties	7.73%	2.61%	1.09%
Howard Hughes	8.04%	5.41%	1.61%

Howard Hughes has lower revenue, but higher earnings than Healthpeak Properties. Howard Hughes is trading at a lower price-to-earnings ratio than Healthpeak Properties, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Healthpeak Properties	$2.82B	5.31	$71.35M	$0.32	67.92
Howard Hughes	$1.51B	2.93	$131.88M	$2.04	36.47

In the previous week, Healthpeak Properties had 5 more articles in the media than Howard Hughes. MarketBeat recorded 5 mentions for Healthpeak Properties and 0 mentions for Howard Hughes. Healthpeak Properties' average media sentiment score of 1.13 beat Howard Hughes' score of 0.00 indicating that Healthpeak Properties is being referred to more favorably in the media.

Company	Overall Sentiment
Healthpeak Properties	Positive
Howard Hughes	Neutral

Healthpeak Properties presently has a consensus target price of $19.93, indicating a potential downside of 8.28%. Howard Hughes has a consensus target price of $85.00, indicating a potential upside of 14.25%. Given Howard Hughes' higher probable upside, analysts plainly believe Howard Hughes is more favorable than Healthpeak Properties.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Healthpeak Properties	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Howard Hughes	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

93.6% of Healthpeak Properties shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 0.2% of Healthpeak Properties shares are held by company insiders. Comparatively, 48.0% of Howard Hughes shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Howard Hughes beats Healthpeak Properties on 9 of the 16 factors compared between the two stocks.

Get Howard Hughes News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HHH vs. The Competition

Export

Metric	Howard Hughes	REAL ESTATE DEV Industry	Finance Sector	NYSE Exchange
Market Cap	$4.44B	$3.18B	$14.02B	$23.34B
Dividend Yield	N/A	6.11%	5.69%	4.04%
P/E Ratio	36.47	9.52	20.66	31.04
Price / Sales	2.93	3.18	131.65	20.76
Price / Cash	11.52	26.33	19.29	25.08
Price / Book	1.50	0.93	2.26	4.78
Net Income	$131.88M	-$9.74M	$1.14B	$1.07B
7 Day Performance	6.29%	-0.27%	1.36%	1.23%
1 Month Performance	18.01%	5.38%	1.89%	2.25%
1 Year Performance	7.73%	6.34%	12.54%	19.23%

Howard Hughes Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HHH Howard Hughes	1.7875 of 5 stars	$74.40 +2.6%	$85.00 +14.3%	+6.2%	$4.44B	$1.51B	36.47	608
TSHA Taysha Gene Therapies	3.11 of 5 stars	$6.91 +5.8%	$12.38 +79.2%	+184.2%	$1.99B	$9.77M	N/A	180	Analyst Forecast
CG Carlyle Group	4.5374 of 5 stars	$43.14 -3.2%	$62.00 +43.7%	-19.9%	$15.53B	$4.78B	29.55	2,500	Options Volume
TPG TPG	4.7517 of 5 stars	$39.38 -4.4%	$61.75 +56.8%	-23.4%	$15.13B	$4.67B	179.01	1,900
REG Regency Centers	4.0001 of 5 stars	$78.62 +1.6%	$82.27 +4.6%	+11.6%	$14.40B	$1.55B	27.11	440	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HHH) was last updated on 7/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Howard Hughes (HHH) Competitors

HHH vs. TSHA, CG, TPG, REG, and DOC

How does Howard Hughes compare to Taysha Gene Therapies?

Summary

How does Howard Hughes compare to Carlyle Group?

Summary

How does Howard Hughes compare to TPG?

Summary

How does Howard Hughes compare to Regency Centers?

Summary

How does Howard Hughes compare to Healthpeak Properties?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HHH vs. The Competition

Howard Hughes Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Howard Hughes (HHH) Competitors

HHH vs. TSHA, CG, TPG, REG, and DOC

How does Howard Hughes compare to Taysha Gene Therapies?

Which has better earnings and valuation, HHH or TSHA?

Which has more risk and volatility, HHH or TSHA?

Do insiders and institutionals believe in HHH or TSHA?

Does the media prefer HHH or TSHA?

Is HHH or TSHA more profitable?

Do analysts rate HHH or TSHA?

Summary

How does Howard Hughes compare to Carlyle Group?

Do insiders & institutionals believe in HHH or CG?

Does the media refer more to HHH or CG?

Do analysts prefer HHH or CG?

Which has more risk and volatility, HHH or CG?

Is HHH or CG more profitable?

Which has better valuation & earnings, HHH or CG?

Summary

How does Howard Hughes compare to TPG?

Which has more volatility & risk, HHH or TPG?

Do analysts recommend HHH or TPG?

Which has preferable valuation & earnings, HHH or TPG?

Does the media prefer HHH or TPG?

Do institutionals and insiders believe in HHH or TPG?

Is HHH or TPG more profitable?

Summary

How does Howard Hughes compare to Regency Centers?

Do insiders and institutionals have more ownership in REG or HHH?

Does the media refer more to REG or HHH?

Which has stronger earnings and valuation, REG or HHH?

Do analysts rate REG or HHH?

Is REG or HHH more profitable?

Which has more volatility and risk, REG or HHH?

Summary

How does Howard Hughes compare to Healthpeak Properties?

Which has more volatility & risk, DOC or HHH?

Is DOC or HHH more profitable?

Which has preferable valuation and earnings, DOC or HHH?

Does the media prefer DOC or HHH?

Do analysts rate DOC or HHH?

Do insiders & institutionals believe in DOC or HHH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HHH vs. The Competition

Howard Hughes Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools